Back to search

Article

The Oncology: Disease Modifying Anti-Rheumatic Drug Interface: A Cross-Specialty Review

2026-05-27

Abstract excerpt

The rapid expansion of biologic therapies for immune-mediated inflammatory diseases has raised significant clinical concerns regarding malignancy risk, particularly for patients with a history of cancer. This narrative review explores the safety of targeted therapies across dermatology, rheumatology, respiratory medicine, and gastroenterology to guide clinicians in these therapeutic dilemmas. We conducted a non-sy...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
24870b76-78c1-509b-82ea-1b527d46a79b
DOI
10.20944/preprints202605.1818.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The Oncology: Disease Modifying Anti-Rheumatic Drug Interface: A Cross-Specialty ReviewDOI 10.20944/preprints202605.1818.v1
Long-term mortality outcomes among immunotherapy recipients treated with dupilumab for the management of cutaneous immune-related adverse eventsSemantic proximity
Biologic Treatment for Cutaneous Immune-Related Adverse Events in Cancer Patients Undergoing Immune-Checkpoint Therapy: A Retrospective ReviewSemantic proximity
Pre-Existing Inflammatory Disease Predicts Cutaneous Immunotherapy Toxicity Development: A Multi-Institutional Cohort StudySemantic proximity
Bridging pharmacovigilance and genetic insight: investigating drugs and indications for breast cancer risk in women with autoimmune diseases.Semantic proximity
Leveraging Multi-tissue, Single-Cell Atlases as Tools to Elucidate Shared Mechanisms of Immune-Mediated Inflammatory DiseasesSemantic proximity
Risankizumab: Mechanism of action, clinical and translational scienceSemantic proximity
Safety outcomes in patients with rheumatoid arthritis treated with abatacept: results from a multinational surveillance study across seven European registriesSemantic proximity
Safety of JAK and IL-6 inhibitors in rheumatoid arthritis: a multicentor cohort studySemantic proximity
Bridging clinical phenotypes with molecular mechanisms in autoimmune irAEs: An Etiopathogenic framework.Semantic proximity
Prediction and treatment of skin adverse reactions related to inhibitors at immune checkpointsSemantic proximity
Silencing of immune activation with methotrexate in patients with COVID-19Semantic proximity
Dermatologic disease in Inflammatory Bowel Disease: a 10-year, 401-patient cohort from a dedicated IBD– Dermatology ProgramSemantic proximity
Select a neighboring publication to make it the new centre.